Follicular Lymphoma: Does it Need Immunohistochemistry?

Follicular lymphoma usually requires immunohistochemical testing to determine tumor type and subtype, assess prognosis, and respond to treatment, and the results of immunohistochemical testing need to be interpreted by a specialist pathologist. Follicular lymphoma usually requires immunohistochemical testing. Immunohistochemistry is a method of detecting protein expression in tissues or cells by using specific antibodies. Immunohistochemistry can provide important information for the diagnosis and classification of follicular lymphoma. Immunohistochemistry allows doctors to identify specific proteins expressed by tumor cells, which can help determine tumor type and subtype. For example, the expression of proteins such as CD10, BCL-2 and BCL-6 is important for the diagnosis and classification of follicular lymphoma. Immunohistochemistry can also be used to assess tumor prognosis and response to treatment. The expression of certain proteins may be associated with tumor aggressiveness and sensitivity to treatment, and doctors can use this information to develop more personalized treatment plans. It should be noted that immunohistochemical tests require interpretation and diagnosis by a professional pathologist. The diagnosis and treatment of follicular lymphoma is based on the results of immunohistochemistry combined with clinical symptoms and imaging tests. Immunohistochemistry is an important step in assessing the disease and selecting treatment options. Patients and family members should fully communicate with their doctors before receiving treatment to understand the significance of immunohistochemistry and the impact of results on treatment. If you or someone close to you is diagnosed with follicular lymphoma, it is recommended to consult a specialist hematologist who will be able to develop an appropriate treatment plan based on the specific situation and provide personalized medical advice.